Trials / Unknown
UnknownNCT01830998
Early Detection of Cognitive Dysfunction in Diabetes
Study of Cognitive Dysfunction and Diabetes
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (estimated)
- Sponsor
- Wuhan General Hospital of Guangzhou Military Command · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The rate of cognitive decline due to ageing is increased 1.5-fold to 2.0-fold in individuals with type 2 diabetes.There are no established specific treatment measures to prevent or ameliorate cognitive impairments in patients with diabetes. we want to detecte early clinical dementia in diabete.
Detailed description
Clinically relevant cognitive decrements in relation to diabetes mainly occur during two crucial periods in life: the period of brain development in childhood, and the period when the brain undergoes neurodegenerative changes associated with ageing.Potential leads for treatment are to optimise glycaemic control and avoid and treat vascular risk factors.we want to detecte early clinical dementia in diabete by MMSE and Olfactory function.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2014-12-01
- Completion
- 2014-12-01
- First posted
- 2013-04-12
- Last updated
- 2014-12-10
Locations
3 sites across 1 country: China
Source: ClinicalTrials.gov record NCT01830998. Inclusion in this directory is not an endorsement.